The Democratic National Committee is launching a new website today to show the impact of President Donald Trump’s tariffs and ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

Johnson & Johnson (JNJ) has reportedly revised its forecast of the impact of U.S. President Donald Trump’s tariffs to $200 ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent tariffs on imports.

The EU as a whole has an annual trade surplus with the United States of $235.6 billion, according to the Bureau of Economic ...

The news comes as the administration is pushing for pharmaceutical manufacturers reshore drug production in the United States.

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.